Pediatric rheumatology

Haematological and other manifestions in the presence of antiphospholipid antibodies in a multicentric paediatric cohort

Clin Exp RheumatolPublished Retrospective cohort study

Authors' conclusion

Non-criteria manifestations and among them haematological disorders, are the most frequent events in the presence of aPLs and/or LA in our paediatric cohort. Children with SLE, LA and/or IgG aβ2GPI positivity showed a higher risk of haematological manifestations.

Study context

Population
Children under the age of 18 years with aPLs
Participants
134 participants
Outcome
Variables associated with haematological manifestations in the presence of aPLs
Methodological detailsmulticentric
  • Multicentric

Main finding

As reported in the abstract

Independent risk factors for haematological manifestations (stepwise regression)
IgG aβ2GPI positivity: OR 2.91, 95% CI (1.26-6.74)
p=0.013
SLE: OR 2.67, 95% CI (1.13-6.3)
p=0.026
LA positivity: OR 2.53, 95% CI (1.08-5.94)
p=0.033

Observational data: associations, not effects.

Further findings

Manifestations in the cohort

At least one thrombotic event
12.2%
At least one non-criterion manifestation
67%
Of them, no thrombotic event (TE)
90%
Haematological
42%
Neurological
19.8%
Cutaneous
17.6%
Cardiac
16.8%
Renal
1.5%

aPL positivity in children with haematological disorders

LA
67.3%
aβ2GPI
65.6%
aCL
60%
Single
45.5%
Double
23.6%
Triple
30.9%

Univariate: higher frequency of haematological manifestations with IgM aCL+, IgM aβ2GPI+, triple positivity and SLE

Significantly higher frequency
P < 0.05

Original publication

Haematological and other manifestions in the presence of antiphospholipid antibodies in a multicentric paediatric cohort. Clin Exp Rheumatol. Published 9 March 2023. doi:10.55563/clinexprheumatol/3mzh06

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.